T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2

Journal of Immunology

Volumn 160, Issue 12, 1998, Pages 6093-6100

  Milligan, Gregg N ^a,b   Bernstein, David I ^a   Bourne, Nigel ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HERPES ZOSTER; HOST RESISTANCE; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSORY GANGLION; T LYMPHOCYTE; VAGINA MUCOSA; VIRUS RESISTANCE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GANGLIA, SENSORY; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; IMMUNITY, MUCOSAL; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; MUCOUS MEMBRANE; T-LYMPHOCYTES; VAGINA;

EID: 0032526336     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Stevens, J. G. 1989. Human herpesvirus: a consideration of the latent state. Microbiol. Rev. 53:318.
2. Hill. T. J. 1985. Herpes simplex virus latency. In The Herpesviruses, Vol. 3. B. Roizman, ed. Plenum Press, New York, p. 175.
3. Stevens, J. G., and M. L. Cook. 1971. Latent herpes simplex in spinal ganglia of mice. Science 173:843.
4. Stevens, J. G., E. K. Wagner, G. B. Devi-Rao, M. L. Cook, and L. T. Feldman. 1987. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 235:1056.
5. Farrell, M. J., A. T. Dobson, and L. T. Feldman. 1991. Herpes simplex virus latency-associated transcript is a stable intron. Proc. Natl. Acad. Sci. USA 88:790.
6. Meignier, B., R. Longnecker, and B. Roizman. 1988. In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents. J. Infect. Dis. 158:602.
7. Milligan, G. N., and D. I. Bernstein. 1995. Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract. Virology 206:234.
8. Stanberry, L. R., D. I. Bernstein, S. Kit, and M. G. Myers. 1986. Genital reinfection after recovery from initial genital infection with herpes simplex virus type 2 in guinea pigs. J. Infect. Dis. 153:1055.
9. Meignier, B., T. M. Jourdier, B. Norrild, L. Pereira, and B. Roizman. 1987. Immunization of experimental animals with reconstituted glycoprotein mixtures of herpes simplex virus 1 and 2: protection against challenge with virulent virus. J. Infect. Dis. 155:921.
10. Stanberry, L. R., D. I. Bernstein, R. L. Burke, C. Pachl, and M. G. Myers. 1987. Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes. J. Infect. Dis. 155:914.
11. Anderson, C. A., M. J. August, and G. D. Hsiung. 1980. Pathogenicity of wild-type and temperature-sensitive mutants of herpes simplex virus type 2 in guinea pigs. Infect. Immun. 30:159.
12. Klein, R. J., L. A. Kaley, and A. E. Friedman-Kien. 1984. Protection against establishment of latent infections in mice immunized with a non-pathogenic herpes simplex virus mutant and reinfected with the pathogenic parental strain. Vaccine 2:219.
13. Tullo, A. B., C. Shimeld, W. A. Blyth, T. J. Hill, and D. L. Easty. 1982. Spread of virus and distribution of latent infection following ocular herpes simplex in the non-immune and immune mouse. J. Gen. Virol. 63:95.
14. Price, R. W., M. A. Walz, C. Wohlenberg, and A. L. Notions. 1975. Latent infection of sensory ganglia with herpes simplex virus: efficacy of immunization. Science 188:938.
15. Centifanto-Fitzgerald, Y. M., E. D. Varnell, and H. E. Kaufman. 1982. Initial herpes simplex virus type 1 infection prevents ganglionic superinfection by other strains. Infect. Immun. 35:1125.
16. Milligan, G. N., and D. I. Bernstein. 1997. Interferon-γ enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology 229:259.
17. Bourne, N., L. R. Stanberry, D. I. Bernstein, and D. Lew. 1996. DNA immunization against experimental genital herpes virus infection. J. Infect. Dis. 173:800.
18. McDermott, M. R., J. R. Smiley, P. Leslie, J. Brais, H. E. Rudzroga, and J. Bienenstock. 1984. Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. J. Virol. 51:747.
19. Milligan, G. N., and D. I. Bernstein. 1995. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2. Virology 212:481.
20. Smith, P. M., R. M. Wolcott, R. Chervenak, and S. R. Jennings. 1994. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-γ (IFN-γ). Virology 202:76.
21. Bouley, D. M., S. Kanangat, W. Wire, and B. T. Rouse. 1995. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-γ knockout mice. J. Immunol. 155:3964.
22. McDermott, M. R., P. L. J. Brais, G. C. Goettsche, J. J. Evelegh, and C. H. Goldsmith. 1987. Expression of immunity to intravaginal herpes simplex virus type 2 infection in the genital tract and associated lymph nodes. Arch. Virol. 93:51.
23. McDermott, M. R., C. H. Goldsmith, K. L. Rosenthal, and L. J. Brais. 1989. T lymphocytes in genital lymph nodes protect mice from intravaginal infection with herpes simplex virus type 2. J. Infect. Dis. 159:460.
24. Simmons, A., and A. A. Nash. 1984. Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. J. Virol. 52:816.
25. Kapoor, A. K., A. A. Nash, and P. Wildy. 1982. Pathogenesis of herpes simplex virus in B cell-suppressed mice: the relative roles of cell mediated and humoral immunity. J. Gen. Virol. 61:127.
26. Simmons, A., D. Tscharke, and P. Speck. 1992. The role of immune mechanisms in control of herpes simplex virus infection of the peripheral nervous system. Curr. Top. Microbiol Immunol. 179:31.
27. + T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J. Gen. Virol. 68:825.
28. Larson, H., M. F. Feng, D. W. Horohov, R. N. Moore, and B. T. Rouse. 1984. Role of T-lymphocyte subsets in recovery from herpes simplex virus infection. J. Virol. 50:56.
29. Manickan, E., and B. T. Rouse. 1995. Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse models. J. Virol. 69:8178.
30. Kolaitis, G., M. Doymaz, and B. T. Rouse. 1990. Demonstration of MHC class II-restricted cytotoxic T lymphocytes in mice against herpes simplex virus. Immunology 71:101.
31. Parr, M. B., L. Kepple, M. R. McDermott, M. D. Drew, J. J. Bozzola, and E. L. Parr. 1994. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab. Invest. 70:369.
32. Mikloska, Z., A. M. Kesson, M. E. T. Penfold, and A. L. Cunningham. 1996. Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-γ. J. Infect. Dis. 173:7.
33. Rossol-Voth, R., S. Rossol, K. H. Schutt, S. Corridori, W. de Cian, and D. Falke. 1991. In vivo protective effect of tumour necrosis factor α against experimental infection with herpes simplex virus type 1. J. Gen. Virol. 72:143.
34. Chan, W. L., H. J. Ziltener, and F. Y. Liew. 1990. Interleukin-3 protects mice from acute herpes simplex virus infection. Immunology 71:358.
35. Feduchi, E., and L. Carrasco. 1991. Mechanism of inhibition of HSV-1 replication by tumor necrosis factor and interferon γ. Virology 180:822.
36. Wu, L., and P. S. Morahan. 1992. Macrophages and other nonspecific defenses: role in modulating resistance against herpes simplex virus. Curr. Top. Microbiol. Immunol. 179:89.
37. Van Strijp, J. A. G., K. P. M. VanKessel, M. E. Van der Tol, and J. Verhuef. 1984. Complement mediated phagocytosis of herpes simplex virus by granulocytes. J. Clin. Invest. 84:107.
38. Oleske, J. M., R. V. Ashman, S. Kohl, S. L. Shore, S. E. Starr, P. Wood, and A. J. Nahmias. 1977. Human polymorphonuclear leukocytes as mediators of antibody dependent cellular cytotoxicity to herpes simplex virus-infected cells. Clin. Exp. Immunol. 27:446.
39. Siebens, H., S. S. Trevethia, and B. M. Babior. 1979. Neutrophil-mediated antibody-dependent killing of herpes simplex-virus infected cells. Blood 54:88.
40. Croen, K. D. 1993. Evidence for an antiviral effect of nitric oxide: inhibition of herpes simplex virus type 1 replication. J. Clin. Invest. 91:2446.
41. Koff, W. C., S. D. Showalter, D. A. Seniff, and B. Hampar. 1983. Lysis of herpesvirus-infected cells by macrophages activated with free or liposome-encapsulated lymphokine produced by a murine T cell hybridoma. Infect. Immun. 42:1067.
42. Klein, R. J. 1980. Effect of immune serum on the establishment of herpes simplex virus infection in trigeminal ganglia of hairless mice. J. Gen. Virol. 49:401.
43. McKendall, R. R. 1983. Delayed IgG-mediated clearance of herpes simplex virus type 1 from the CNS but not footpad during the early stages of infection: possible result of relative integrity of the blood-brain barrier. J. Gen. Virol. 64:1965.
44. Shimeld, C., T. J. Hill, W. A. Blyth, and D. L. Easty. 1990. Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system. J. Gen. Virol. 71:681.
45. Kapoor, A. K., A. A. Nash, P. Wildy, J. Phelan, C. S. McLean, and H. J. Field. 1982. Pathogenesis of herpes simplex virus in congenitally athymic mice: the relative roles of cell-mediated and humoral immunity. J. Gen. Virol. 60:225.
46. Kino, Y., Y. Hayashi, I. Hayashida, and R. Mori. 1982. Dissemination of herpes simplex virus in nude mice after intracutaneous inoculation and effect of antibody on the course of infection. J. Gen. Virol. 63:475.
47. Simmons, A., and A. A. Nash. 1987. Effect of B cell suppression on primary infection and reinfection of mice with herpes simplex virus. J. Infect. Dis. 155:649.
48. Bonneau, R. H., and S. R. Jennings. 1989. Modulation of acute and latent herpes simplex virus infection in C57BL/6 mice by adoptive transfer of immune lymphocytes with cytolytic activity. J. Virol. 63:1480.
49. Cook, M. L., and J. G. Stevens. 1973. Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection. Infect. Immun. 7:272.
50. McKendall, R. R., T. Klassen, and J. R. Baringer. 1979. Host defenses in herpes simplex infection of the nervous system: effect of antibody on disease and viral spread. Infect. Immun. 23:305.
51. Liu, T., Q. Tang, and R. L. Hendricks. 1996. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 70:264.
52. Cantin, E. M., D. R. Hinton, J. Chen, and H. Openshaw. 1995. Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J. Virol. 69:4898.
53. Simmons, A., and D. C. Tscharke. 1992. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J. Exp. Med. 175:1337.
54. + cells. J. Virol. 65:6008.
55. Thapar, M. A., E. L. Parr, and M. B. Parr. 1990. Secretory immune responses in mouse vaginal fluid after pelvic, parenteral, or vaginal immunization. Immunology 70:121.